Begin main content

Reports

We found 5404 result(s)

pegfilgrastim (Fulphila )

Last Updated: December 20, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: pegfilgrastim
Indications: Febrile neutropenia in non-myeloid malignancies

  • Brand Name: Fulphila
  • Manufacturer: BGP PHARMA ULC
  • Project Number: SE0588-000
  • Project Status: Complete
  • Submission Type: New

Tags

Blood, Cancer, Blood, Cancer

cerliponase alfa (Brineura)

Last Updated: December 21, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: cerliponase alfa
Indications: Neuronal Ceroid Lipofuscinosis Type 2

  • Brand Name: Brineura
  • Manufacturer: Biomarin Pharmaceutical (Canada) Inc.
  • Project Number: SR0574-000
  • Project Status: Active
  • Submission Type: New

Tags

Genetics, Nervous System, Lipid Metabolism Disorders, Genetics, Nervous system, neuronal ceroid lipofuscinosis; neuronal ceroid lipofuscinoses; ceroid storage disease; Batten disease; cln2; Batten diseases; ceroid storage diseases; brineura; cerliponase alfa; cerliponase alpha

dolutegravir / lamivudine (TBC)

Last Updated: February 22, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: dolutegravir / lamivudine
Indications: HIV-1 infection

  • Brand Name: TBC
  • Manufacturer: ViiV Healthcare
  • Project Number: SR0601-000
  • Project Status: Received
  • Submission Type: New

Tags

Infectious Diseases, Pediatrics, HIV/AIDS, Infectious diseases, Pediatrics

Programs for the Treatment of Opioid Addiction in Canada

Published on: February 22, 2019
Result type: Reports
Product Line: Environmental Scans
Research Type: Device

CADTH is undertaking an Environmental Scan to understand the current context surrounding opioid addiction programs, including opioid agonist therapies and other non-pharmacological programming, and care setting transitions across Canada. The key objectives of this Environmental Scan are to: describe the opioid addiction treatment programs that a...

  • Project Number: ES0335-000

Tags

Mental Health, Mental health

onabotulinumtoxinA (Botox)

Last Updated: December 17, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: onabotulinumtoxinA
Indications: migraine, chronic

  • Brand Name: Botox
  • Manufacturer: Allergan Inc.
  • Project Number: SR0584-000
  • Project Status: Active
  • Submission Type: Resubmission

Tags

Headache Disorders, Nervous System, Headache disorders, Nervous system

baricitinib (Olumiant )

Last Updated: December 24, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: baricitinib
Indications: Arthritis, Rheumatoid

  • Brand Name: Olumiant
  • Manufacturer: Eli Lilly Canada Inc.
  • Project Number: SR0597-000
  • Project Status: Active
  • Submission Type: New

Tags

Arthritis, Arthritis, Musculoskeletal

patisiran (Onpattro)

Last Updated: February 20, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: patisiran
Indications: Polyneuropathy in hereditary transthyretin-mediated amyloidosis

  • Brand Name: Onpattro
  • Manufacturer: Alnylam Netherlands BV
  • Project Number: SR0598-000
  • Project Status: Active
  • Submission Type: New

Tags

Genetics, Nervous System, Genetics, Nervous system

semaglutide (Ozempic)

Last Updated: December 24, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: semaglutide
Indications: Diabetes mellitus, type 2

  • Brand Name: Ozempic
  • Manufacturer: Novo Nordisk Canada Inc.
  • Project Number: SR0594-000
  • Project Status: Active
  • Submission Type: New

Tags

Diabetes

Nusinersen (Spinraza)

Last Updated: February 20, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: Nusinersen
Indications: Spinal Muscular Atrophy

  • Brand Name: Spinraza
  • Manufacturer: Biogen Canada Inc.
  • Project Number: SR0576-000
  • Project Status: Active
  • Submission Type: Resubmission

Tags

Genetics, Nervous System, Pediatrics, Muscular Atrophy, Spinal, Genetics, Musculoskeletal, Nervous system, Pediatrics, spinal muscular atrophy; nusinersen; Spinraza

telotristat (Xermelo)

Last Updated: December 20, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: telotristat
Indications: carcinoid syndrome

  • Brand Name: Xermelo
  • Manufacturer: Ipsen Biopharmaceuticals Canada Inc.
  • Project Number: SR0580-000
  • Project Status: Active
  • Submission Type: New

Tags

Cancer, Cancer